George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.60
Bid: 100.20
Ask: 101.60
Change: -0.20 (-0.20%)
Spread: 1.40 (1.397%)
Open: 100.80
High: 104.20
Low: 100.20
Prev. Close: 101.80
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

23 Nov 2023 07:00

RNS Number : 3941U
PZ CUSSONS PLC
23 November 2023
 

 

23 November 2023

AGM TRADING STATEMENT

 

Ahead of its Annual General Meeting which takes place today, PZ Cussons issues the following update on current trading and developments in Nigeria.

Trading update

 

Trading has continued to be in line with expectations and consistent with the FY24 outlook provided at our FY23 full year results on 26 September.

 

The Group expects to report low-single-digit like-for-like revenue growth for H1 FY24. This reflects strong growth in Nigeria and ANZ offset by a decline in Indonesia. Our Europe and Americas business is stable overall, with significantly-improving momentum in our UK washing and bathing brands offset by a decline in our Beauty business.

 

We expect to deliver a robust year-on-year operating margin improvement in H1 FY24 and both revenue growth and operating margin to improve in H2 compared to H1. Further guidance will be provided at our interim results, including the FY24 effective tax rate, non-controlling interest and net interest charge, each of which will be largely driven by trading in Nigeria and other developments there.

 

Nigeria update

 

Building on the strategic progress already made in Nigeria since the loss-making position in FY20, trading in the first half of the year has continued to be strong. The majority of our brands have held or gained market share and we have seen no material change in our volume trends in recent weeks[1]. We expect to achieve an improvement in both gross and operating profit margins in the first half of the year, despite very high levels of inflation.

 

As noted in September at our full year results, the lack of availability of US Dollars in Nigeria has created significant challenges for the day-to-day funding of the Nigerian business and the repatriation of cash to the Group's holding companies. This issue was exacerbated in June 2023, following the new government's liberalisation of the FX regime and resulting devaluation of the Naira. We have since accelerated both our operational and corporate plans, enabling us to mitigate these risks so far in FY24. More broadly, in recent weeks, FX market liquidity has shown tentative signs of improvement.

 

As a result:

 

· Our business in Nigeria expects to be able to continue to meet its needs for the foreign currency required for day-to-day operations, which will eliminate the need for further lending from the Group's holding companies.

· We have also started to repatriate cash in recent weeks which, combined with underlying strong free cash flow, is expected to result in a c. £20 million reduction in Group gross debt since 31 May 2023[2].

· Based on prevailing rates, the current Naira cash balance is equivalent to c. £80-100 million[3]. Assuming current market conditions persist, the Group aims to repatriate a further £30-50 million of cash by the end of FY24.

· The proposed transaction to de-list and buy out the minority shareholdings of PZ Cussons Nigeria plc is progressing as planned. The Group welcomes the recent recommendation of the Board of PZ Cussons Nigeria to minority shareholders to accept a revised offer of ?23 per share[4] and expects the transaction to complete before 31 May 2024. The purchase of the minority shareholdings will be funded from our local Naira cash balance.

· We therefore expect only a minimal surplus cash position remaining in Nigeria, beyond that required for trading, by the end of this financial year.

 

Additional sensitivities and implications of the devaluation in the Naira, which will impact the H1 FY24 reported results, were set out in our Trading Statement on 27 June 2023.

 

***

 

The Group will report its FY24 interim results on Wednesday 7 February 2024.

 

For further information please contact:

Investors

Simon Whittington - IR and Corporate Development Director +44 (0) 77 1137 2928

 

Media

Headland PZCussons@headlandconsultancy.com +44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

 

Notes to Editors

 

About PZ Cussons

 

PZ Cussons is a FTSE250 listed consumer goods business headquartered in Manchester, UK. We employ nearly 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St. Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy and captured by our purpose: For everyone, for life, for good.


[1] Source: market share for the Nigeria Hygiene, Baby and Beauty business based on the 12 months to September 2023 (Nielsen Retail Audit)

[2] As at the end of November, after the payment of the FY23 final dividend

[3] £80-100 million based upon NGN/USD rates of 1,000 and 1,200 which is the range within which US Dollars have been sourced during October and November and compares to a current official rate of approximately 800

[4] Equivalent to £25 million based on USD/GBP rate of 1.24 and an assumed NGN/USD rate of 800 which is the approximate current official rate

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLLLLLXFLZFBD
Date   Source Headline
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.